EU healthcare workers say they ‘refuse to be instruments’ in deportation plans | European Union

EU healthcare workers say they ‘refuse to be instruments’ in deportation plans | European Union

More than 1,100 healthcare professionals from across Europe have urged MEPs to reject proposed measures aimed at increasing the deportation of undocumented people, warning they could threaten public health by transforming essential public services, including hospitals, into sites of immigration enforcement. The draft plans, which are due to go to a vote on Thursday, have…

Read More
Estradiol Patch Matches LHRH Agonists for Locally Advanced Prostate Cancer

Estradiol Patch Matches LHRH Agonists for Locally Advanced Prostate Cancer

Transdermal estradiol patches and LHRH agonists led to similar metastasis-free and overall survival in locally advanced prostate cancer. Estradiol was associated with substantially lower incidence of hot flashes but substantially more gynecomastia. Unlike oral estrogen, transdermal estradiol avoids first-pass hepatic metabolism, lowering the risk of thromboembolic cardiovascular complications. Transdermal estradiol for locally advanced prostate cancer…

Read More

RSV shots for babies under FDA review despite evidence of safety : NPR

An electron microscope image provided by the National Institutes of Health shows human respiratory syncytial virus virions, colorized blue, and antibodies against an RSV protein, colorized yellow. AP/National Institute of Allergy and Infectious Diseases, NIH hide caption toggle caption AP/National Institute of Allergy and Infectious Diseases, NIH Health and Human Services Secretary Robert F. Kennedy…

Read More
FDA Approves New Drug Combo for Tough-to-Treat Ovarian Cancer

FDA Approves New Drug Combo for Tough-to-Treat Ovarian Cancer

The FDA approved relacorilant (Lifyorli) in combination with nab-paclitaxel (Abraxane) for the treatment of adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. The combination of the selective glucocorticoid receptor antagonist and chemotherapy drug is indicated for patients who have received one to three prior lines of therapy, at least one of which…

Read More